Recent Finacing
Recent Raise
AlloCure is a clinical-stage biotech developing AC607, a biologic for acute kidney injury and other serious illnesses, and initiating a multicenter randomized double-blind placebo-controlled U.S. trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors